Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$814M |
| 2 |
NVIDIA
NVDA
|
+$448M |
| 3 |
Microsoft
MSFT
|
+$394M |
| 4 |
Apple
AAPL
|
+$368M |
| 5 |
Johnson & Johnson
JNJ
|
+$288M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$616M |
| 2 |
Tesla
TSLA
|
+$406M |
| 3 |
Palo Alto Networks
PANW
|
+$400M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$394M |
| 5 |
AT&T
T
|
+$389M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.96% |
| 2 | Technology | 19.63% |
| 3 | Consumer Staples | 10.59% |
| 4 | Consumer Discretionary | 10.5% |
| 5 | Communication Services | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Schwab Fundamental International Large Company Index ETF
FNDF
$25.8B
| $1.3M | ﹤0.01% |
39,200
-27,600
| -41% | -$928K |
|
|
OPTN
2527
DELISTED
OptiNose
OPTN
| $1.3M | ﹤0.01% |
27,811
+358
| +1% | +$18.3K |
|
|
ADAP
2528
DELISTED
Adaptimmune Therapeutics
ADAP
| $1.29M | ﹤0.01% |
303,495
+202,495
| +200% | +$983K |
|
2529
ClearOne Inc
CLRO
$15.2M
| $1.29M | ﹤0.01% |
31,451
-2,066
| -6% | -$77.7K |
|
|
WRN
2530
Western Copper and Gold
WRN
$541M
| $1.29M | ﹤0.01% |
649,100
+2,000
| +0.3% | +$3.67K |
|
2531
First Commonwealth Financial
FCF
$2.19B
| $1.29M | ﹤0.01% |
91,700
-36,700
| -29% | -$539K |
|
|
RNTX
2532
Rein Therapeutics
RNTX
$67.4M
| $1.29M | ﹤0.01% |
51,556
-10,969
| -18% | -$274K |
|
2533
iShares Expanded Tech-Software Sector ETF
IGV
$15.2B
| $1.29M | ﹤0.01% |
+16,500
| New | +$1.2M |
|
2534
Legacy Housing
LEGH
$692M
| $1.28M | ﹤0.01% |
76,000
+43,500
| +134% | +$804K |
|
|
TRT
2535
Trio-Tech International
TRT
$118M
| $1.28M | ﹤0.01% |
511,058
+25,600
| +5% | +$64.9K |
|
|
ZSAN
2536
DELISTED
Zosano Pharma Corporation
ZSAN
| $1.28M | ﹤0.01% |
+38,623
| New | +$1.24M |
|
2537
Citizens
CIA
$198M
| $1.28M | ﹤0.01% |
242,494
-38,500
| -14% | -$212K |
|
2538
StoneX
SNEX
$8.05B
| $1.28M | ﹤0.01% |
+106,804
| New | +$1.38M |
|
2539
Standard Motor Products
SMP
$870M
| $1.28M | ﹤0.01% |
+29,500
| New | +$1.32M |
|
2540
Alpha Metallurgical Resources
AMR
$1.97B
| $1.28M | ﹤0.01% |
49,815
-65,000
| -57% | -$1.12M |
|
|
APLS
2541
DELISTED
Apellis Pharmaceuticals
APLS
| $1.28M | ﹤0.01% |
20,211
-353,302
| -95% | -$18.2M |
|
2542
PCB Bancorp
PCB
$400M
| $1.28M | ﹤0.01% |
79,276
+24,444
| +45% | +$383K |
|
|
NP
2543
DELISTED
Neenah, Inc. Common Stock
NP
| $1.27M | ﹤0.01% |
25,300
-53,900
| -68% | -$2.88M |
|
|
VNE
2544
DELISTED
Veoneer, Inc.
VNE
| $1.27M | ﹤0.01% |
+54,769
| New | +$1.3M |
|
2545
Precision BioSciences
DTIL
$201M
| $1.27M | ﹤0.01% |
3,371
-844
| -20% | -$253K |
|
2546
Tecnoglass Holdings Inc.
TGLS
$1.87B
| $1.26M | ﹤0.01% |
59,000
+100
| +0.2% | +$1.66K |
|
|
FSTX
2547
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $1.26M | ﹤0.01% |
147,011
+8,700
| +6% | +$74.2K |
|
|
ESTE
2548
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $1.26M | ﹤0.01% |
114,065
+42,565
| +60% | +$386K |
|
2549
Mueller Industries
MLI
$14.7B
| $1.26M | ﹤0.01% |
116,508
-61,092
| -34% | -$691K |
|
2550
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$14.1B
| $1.26M | ﹤0.01% |
23,800
+3,700
| +18% | +$191K |
|
Similar funds
Jim Simons's Q2 2021 Portfolio in Review
As of Q2 2021, Jim Simons held 3,960 positions worth $80.1B, down 0.34% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $5.63B in Q2 2021, closing 551 positions and reducing 1,699 holdings. Its most notable exit was AT&T, an estimated $389M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Caterpillar worth $227M.
- Jim Simons's largest Q2 2021 buy was Caterpillar: 1,042,778 shares worth $227M.
- Jim Simons added most to Amazon in Q2 2021, an estimated $814M increase.
- Jim Simons's biggest Q2 2021 reduction was Baidu, cutting an estimated $616M.
- Jim Simons fully exited AT&T in Q2 2021, selling an estimated $389M.
- Jim Simons's ten largest holdings make up 12% of its $80.1B portfolio in Q2 2021.
- Jim Simons opened 701 new positions and closed 551 in Q2 2021.
- Jim Simons's portfolio value fell 0.34% quarter-over-quarter to $80.1B.
Based on Renaissance Technologies's 13F filing for Q2 2021, filed 13 Aug 2021.